Jordan Croteau has 15+ years of digital systems design and implementation experience in biopharmaceutical manufacturing operations, process development, and facilities. Prior to Moderna, Jordan was responsible for developing the new technology introduction and technology readiness processes at Kite Pharma. Previously, he served as MES lead in the Global Automation Center of Excellence at Biogen, Inc. In this role, Jordan led the global execution system design and its integration with Biogen’s manufacturing and enterprise systems. He is currently a member of ISA and has been an active contributor to ISA 95. Jordan received a BS in Chemical Engineering from Worcester Polytechnic Institute.

Experienced Manufacturing Operations strategist, with a demonstrated history of implementing in the biotechnology industry. Skilled in Enterprise-Control System Integration (ISA 95), MES, Materials Management, Product Lifecycle Management, Process Control, and Oracle ERP.

At Moderna, we believe messenger RNA, or mRNA, is the “software of life.” Every cell in the body uses mRNA to provide real-time instructions to make the proteins necessary to drive all aspects of biology, including in human health and disease. Given its essential role, we believe mRNA could be used to create a new category of medicines with significant potential to improve the lives of patients. We are pioneering a new class of medicines made of messenger RNA, or mRNA. The potential implications of using mRNA as a drug are significant and far-reaching and could meaningfully improve how medicines are discovered, developed and manufactured.